Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)

Immunotherapy is now widely established as a potent and effective treatment option across several types of cancer. However, there is increasing recognition that not all patients respond to immunotherapy, focusing attention on the immune contexture of the tumor microenvironment (TME), drivers of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascierto, Paolo A., Bifulco, Carlo, Buonaguro, Luigi, Emens, Leisha A., Ferris, Robert L., Fox, Bernard A., Delgoffe, Greg M., Galon, Jérôme, Gridelli, Cesare, Merlano, Marco, Nathan, Paul, Odunsi, Kunle, Okada, Hideho, Paulos, Chrystal M., Pignata, Sandro, Schalper, Kurt A., Spranger, Stefani, Tortora, Giampaolo, Zarour, Hassane, Butterfield, Lisa H., Puzanov, Igor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884742/
https://www.ncbi.nlm.nih.gov/pubmed/31783779
http://dx.doi.org/10.1186/s40425-019-0798-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884742/
https://www.ncbi.nlm.nih.gov/pubmed/31783779
http://dx.doi.org/10.1186/s40425-019-0798-3

Ejemplares similares